# Stoke Therapeutics, Inc.: Form 8-K/A, filed Sep 18, 2025

- Company: [Stoke Therapeutics, Inc.](/companies/stok.md) (CIK 1623526)
- Form: 8-K/A
- Filed: 2025-09-18
- Accepted by EDGAR: Sep 18, 2025, 16:07 ET
- Period: 2025-06-03
- Accession: 0001193125-25-207401
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1623526/000119312525207401/d798098d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1623526/000119312525207401/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1623526/000119312525207401/d798098d8ka.htm

Filed Sep 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-207401. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.